Official website vaccine against coronavirus Sputnik V. The first registered vaccine against COVID-19 Sputnik V.
Serbia and Argentina have started producing Russia's Sputnik V vaccine. Hungary has made similar plans and will start producing the vaccine next year. /Reuters/ Dado Ruvic Serbia and Argentina have started producing Russia's Sputnik V vaccine. Hungary has made similar plans and...
On Monday, Alexander Gintsburg, the director of Moscow’s Gamaleya Institute, which developed Sputnik V, the country’s first domestic Covid-19 vaccine for humans, warned animals could become a new frontline in the fight against the virus. He said that the pandemic“has not yet realized its ...
Another adenoviral vector-based vaccine against Middle East Respiratory Syndrome (MERS) is in the advanced stages of clinical trials. Many other COVID-19 vaccine candidates also do use adenoviral vectors, but none uses the two-vector platform developed by the Gamaleya Center. ...
doi:10.30476/ijms.2022.96239.2776COVID-19 vaccinesVACCINE immunogenicityURTICARIADRUG side effectsFATIGUE (Physiology)Varghaei, AidaHeidari, MohammadDaneshyar, ChimanNouri, ArminMikaeilvand, AmirIranian Journal of Medical Sciences
The RDIF has announced that the UAE Ministry of Health and Prevention (MOHAP) authorised Sputnik V vaccine against Covid-19.
To boldly go where no vaccine has gone before? A new video promoting Sputnik V, Russia’s vaccine against Covid-19, envisions the drug as its space namesake zapping into oblivion a giant coronavirus engulfing the entire planet. The computer-generated animation has beenpublishedon the website ...
All participates were adult, had been vaccinated twice with Gam-COVID-Vac vaccine and had no prior history of confirmed COVID-19. In all participants, the levels of anti-SARS-CoV-2-specific IgG were quantified at 1 month and 6 months from the second vaccine shot using ELISA. Specific T-...
We report results on immunogenicity of the recombinant adenovirus (rAd) 26 and rAd5 vector-based COVID-19 vaccine Gam-COVID-Vac (Sputnik V, developed by Gamaleya National Research Centre, Russia) in patients, receiving maintenance hemodialysis (HD). We aimed to compare the dynamics of humoral ...
During the data collection process, we realized that 558 of 675 people working in Imam Hassan hospital had already received at least one dose of a COVID-19 vaccine. Of these 558 individuals, 434 had received a vaccine within the target period (spring 2021) and, therefore, were eligible to...